Pyridostigmine Bromide Tablet
Product Images NDC 0115-2134

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 0115-2134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Pyridostigmine Bromide Tablets Usp 30 mg 1)

Chemical structure of Pyridostigmine Bromide, showing the molecular arrangement including the pyridinium ring, bromide ion, and carbamate functional group.*

FDA Label Image

1 (Pyridostigmine Bromide Tablets Usp 30 mg 2)

Label for Pyridostigmine Bromide Tablets, USP 30 mg oral tablets by Amneal Pharmaceuticals LLC. The unit-of-use packaging contains 21 tablets. The label highlights moisture sensitivity, storage instructions, and child-resistant packaging. It includes the drug strength, manufacturer information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.